Ono Venture Investment

Ono Venture Investment operates as the corporate venture capital arm of Ono Pharmaceutical Co., Ltd., strategically investing in early-stage life science companies. It targets novel products and platforms with potential for drug discovery and development, focusing on immunology, neurology, and oncology. OVI evaluates diverse modalities and technologies to complement its parent company's R&D pipeline.

Ono Pharmaceutical Co., Ltd., a prominent R&D-focused pharmaceutical firm, established Ono Venture Investment to accelerate innovation and expand its therapeutic reach. The parent company recognized external collaboration with startups is crucial for accessing disruptive technologies, augmenting internal research, and securing future drug candidates.

Startups developing groundbreaking therapeutic solutions benefit from OVI's capital and industry expertise. Ono Venture Investment fosters the growth of companies creating next-generation treatments, contributing to new medicine discovery and advancing global healthcare. Its vision aligns with Ono Pharmaceutical's mission of bringing innovative therapies to patients.